Orchard Therapeutics

We’re part of gene therapy history — and its future.

Orchard was founded in 2015—but our roots run deeper, going back to some of the first research and clinical development involving hematopoietic stem cell, or HSC, gene therapy. Our team has played a central role in the evolution of this technology from a promising idea to a potentially life-transforming reality. Today, we carry forward our history of visionary science to imagine new possibilities for people and families affected by genetic and other severe diseases.

Email

Privacy Policy

Website

MIMS Learning Live is a learning series for primary care professionals hosted in a unique in-person or digital format in multiple locations. These events are exclusively for primary healthcare professionals.

This event is made possible by sponsorship from organisations including pharmaceutical companies, med tech companies and service providers who have provided sponsorship towards this independent programme. They have had no editorial input or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the marked sponsored symposia. Sessions delivered with input from these organisations are marked as such on the programme and a list of all sponsors can be found here.

Orchard Therapeutics

Useful links

Our Brands